AUTL
Autolus Therapeutics
AUTL
AUTL
59 hedge funds and large institutions have $164M invested in Autolus Therapeutics in 2021 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
14% less funds holding
Funds holding: 69 → 59 (-10)
50% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 20
Holders
59
Holding in Top 10
–
Calls
$1.22M
Puts
$665K
Top Buyers
| 1 | +$8.17M | |
| 2 | +$7.49M | |
| 3 | +$5.73M | |
| 4 |
JP Morgan Chase
New York
|
+$3.93M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$723K |
Top Sellers
| 1 | -$5.31M | |
| 2 | -$3.93M | |
| 3 | -$3.89M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.72M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.36M |